Insulin Glargine (Monograph)Play pronunciation Brand names: Basaglar, Lantus, Soliqua 100/33 (combination), Toujeo Drug class: Long-acting Insulins ATC class: A10AB01 VA class: HS501 Chemical name: 21A-Glycine-30Ba-l-arginine-30Bb-l-arginine insulin (human) Molecular formula: C267H404N72O...
Usage: Dissolution injection Cas NO.: 160337-95-1 Name: insulin glargine Purity: >99% Brand Name: Lemite Appearance: White freeze-dried powder Melting Point: [81]Packaging & Delivery Packaging Detail: Box/barrel/box/bottle Delivery Detail: 1-7daysProduct Description Name: insulin glargineSyno...
抗体名:Research Grade Insulin Glargine(Biosimilar 抗体) 靶点:Human 用途:供科研使用 保质期:1 year 应用范围:Research Grade Biosimilar 产地:France 包装规格:支 品牌:abinScience 抗原来源:Human 适应物种:Human 形态:Liquid 保存条件:0.01M PBS, pH 7.4. ...
Transfer your prescription for Lantus (Brand for Insulin Glargine, Injectable Solution) on Amazon Pharmacy. FREE SHIPPING for Prime members.
Generic NameBrand NameAvailable Dosage FormsComponents Premixed Combination Insulin Products NPH/regular 70/30Novolin 70/30, Humulin 70/30U-100 vial, U-100 prefilled pen70% insulin isophane, 30% human insulin Lispro 50/50Humalog Mix 50/50U-100 vial, U-100 prefilled pen50% insulin lispro pr...
Insulin glargine is a long-acting human insulin analog to enhance glycemic control in adults and pediatric patients with type 1 diabetes and in adults with type 2 diabetes. Biosimilars are approved by the FDA as having highly similar safety and efficacy to the reference brand and "no clinically...
1A Check the name and expiration date on the label of your pen. Make sure you have the correct insulin. Do notuse your pen after the expiration date. 1B Pull off the pen cap. 1C Check that the insulin is clear. Do not use the pen if the insulin looks cloudy, colored or contains...
INSULIN GLARGINE.Addresses insulin glargine, a form of insulin developed by Aventis Pharmaceuticals Inc. and distributed under the brand name Lantus. Significant ways the medical treatment of diabetes has changed; Importance of glargine to people with diabetes; Results of the clinical trial to learn ...